血尿评估的危害:在理论队列中建模使用分次团注计算机断层尿路造影降低辐射暴露的风险-获益
该研究通过汇总队列研究计算血尿患者肾细胞癌和上尿路尿路上皮癌的患病率,结合分次团注CT尿路造影的敏感度估算漏诊恶性肿瘤风险,并利用终生归因风险估算避免继发恶性肿瘤的获益。模型显示分次团注CT尿路造影在敏感度80%时对50岁以下男性和60岁以下女性镜下血尿患者有益,敏感度90%时获益年龄各提高10岁,总体镜下血尿人群在敏感度91.1%时获益,但肉眼血尿患者需敏感度高达98.4%才总体获益。结论认为分次团注CT尿路造影可在约70%镜下血尿人群中安全实施,但目前不建议用于肉眼血尿或其他高危患者。
要点
- 分次团注CT尿路造影敏感度估计范围为80%至100%(平均95.2%)。
- 敏感度80%时对50岁以下男性和60岁以下女性镜下血尿患者有益。
- 肉眼血尿患者总体获益所需敏感度阈值高达98.4%。
核心结论
- 分次团注CT尿路造影可在约70%的镜下血尿人群中安全实施,但目前不建议用于肉眼血尿或其他高危患者。
研究设计与样本
- 理论研究:基于血尿患者队列研究的汇总分析计算肾细胞癌和上尿路尿路上皮癌患病率,结合分次团注敏感度估算漏诊恶性肿瘤,利用终生归因风险估算避免的继发恶性肿瘤数。
主要发现
- 分次团注CT尿路造影敏感度估计范围为80%至100%(平均95.2%)。
- 敏感度80%时,分次团注CT尿路造影对年龄小于50岁男性和小于60岁女性镜下血尿患者有益。
- 敏感度提高至90%时,男性和女性获益年龄各提高10岁,覆盖68.8%的镜下血尿患者。
- 镜下血尿总体人群在敏感度91.1%时分次团注CT尿路造影即有益。
- 肉眼血尿患者总体获益的敏感度阈值高达98.4%。
关键数值与推荐
- 分次团注CT尿路造影敏感度范围80%至100%(平均95.2%)。
- 镜下血尿患者总体获益所需敏感度为91.1%。
- 肉眼血尿患者总体获益所需敏感度阈值为98.4%。
临床怎么用
- 作者认为分次团注CT尿路造影可在约70%的镜下血尿人群中安全实施。
- 作者认为目前不建议在肉眼血尿或其他高危患者中使用分次团注CT尿路造影。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Computerized tomography urography is used to evaluate patients with gross or microscopic hematuria. Computerized tomography urography is a high radiation dose scan and, thus, it confers a higher risk of secondary malignancy. A computerized tomography urography split bolus protocol reduces radiation exposure but it may reduce sensitivity. In this study we used a theoretical cohort of patients with hematuria in which to model the risk of missing malignancies against the benefit of averting secondary malignancies. MATERIALS AND METHODS: We calculated the prevalence of renal cell carcinoma and upper tract urothelial carcinoma in patients with hematuria by pooled analysis of cohort studies, which in conjunction with split bolus sensitivity allows for the estimation of missed malignancies. The number of prevented secondary malignancies was calculated from lifetime attributable risk estimates. Sensitivity analyses were run to determine the minimum sensitivity required for a net population benefit. RESULTS: Estimates of split bolus computerized tomography urography sensitivity ranged from 80% to 100% (mean 95.2%). At the low estimate of 80% sensitivity split bolus computerized tomography urography was beneficial in men and women with microscopic hematuria at ages less than 50 and less than 60 years, respectively. An increase in sensitivity to 90% improved the benefit 1 decade in each gender, representing 68.8% of patients with microscopic hematuria. The overall population of patients with microscopic hematuria benefited from split bolus computerized tomography urography at 91.1% sensitivity. However, in patients with gross hematuria the threshold for an overall population benefit was high at 98.4% sensitivity. CONCLUSIONS: Exposure to ionizing radiation risks causing secondary malignancy. These data indicate that split bolus computerized tomography urography may be performed safely in 70% of the population of patients with microscopic hematuria. However, it is not currently advisable in patients with gross hematuria or in other patients at high risk.
引用
- Dallmer JR, Robles J, Wile GE, et al. The Harms of Hematuria Evaluation: Modeling the Risk-Benefit of Using Split Bolus Computerized Tomography Urography to Reduce Radiation Exposure in a Theoretical Cohort. J Urol. 2019. PMID: 31188730. doi:10.1097/JU.0000000000000387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。